References
- Uygun V, Karasu G, Daloglu H, et al. Idiopathic hyperammonemia after hematopoietic stem cell transplantation: A case report. Pediatr Transplant. 2015;19(4):E104–E105.
- Frere P, Canivet JL, Gennigens C, et al. Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant. 2000;26(3):343–345. doi:10.1038/sj.bmt.1702485
- Graetz R, Meyer R, Shehab K, et al. Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection. Transpl Infect Dis. 2018;20(2):e12839), doi:10.1111/tid.12839
- Ho AY, Mijovic A, Pagliuca A, et al. Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT). Bone Marrow Transplant. 1997;20(11):1007–1008. doi:10.1038/sj.bmt.1701003
- Laemmle A, Hahn D, Hu L, et al. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Mol Genet Metab. 2015;114(3):438–444. doi:10.1016/j.ymgme.2015.01.002
- Mitchell RB, Wagner JE, Karp JE, et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med. 1988;85(5):662–667. doi:10.1016/S0002-9343(88)80239-0
- Snyder MJ, Bradford WD, Kishnani PS, et al. Idiopathic hyperammonemia following an unrelated cord blood transplant for mucopolysaccharidosis I. Pediatr Dev Pathol. 2003;6(1):78–83. doi:10.1007/s10024-001-0271-3
- Tse N, Cederbaum S, Glaspy JA. Hyperammonemia following allogeneic bone marrow transplantation. Am J Hematol. 1991;38(2):140–141. doi:10.1002/ajh.2830380213
- Davies SM, Szabo E, Wagner JE, et al. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. Bone Marrow Transplant. 1996;17(6):1119–1125.
- Seethapathy H, Fenves AZ. Pathophysiology and management of hyperammonemia in organ transplant patients. Am J Kidney Dis. 2019;74(3):390–398. doi:10.1053/j.ajkd.2019.03.419
- Paparoupa M, Barten MJ, de Heer J, et al. Hyperammonemia by Ureaplasma urealyticum pneumonia after lung transplantation. Respir Med Case Rep. 2020;30:101080.
- Tuchman M, Morizono H, Rajagopal BS, et al. Identification of ‘private’ mutations in patients with ornithine transcarbamylase deficiency. J Inherit Metab Dis. 1997;20(4):525–527. doi:10.1023/A:1005301513465
- Haberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis. 2019;42(6):1192–1230. doi:10.1002/jimd.12100
- Auron A, Brophy PD. Hyperammonemia in review: pathophysiology, diagnosis, and treatment. Pediatr Nephrol. 2012;27(2):207–222. doi:10.1007/s00467-011-1838-5
- Musalkova D, Sticova E, Reboun M, et al. Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency. Virchows Arch. 2018 Jun;472(6):1029–1039. doi:10.1007/s00428-018-2345-x
- Pridmore CL, Clarke JT, Blaser S. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy. J Child Neurol. 1995;10(5):369–374. doi:10.1177/088307389501000506
- Brassier A, Gobin S, Arnoux JB, et al. Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients. Orphanet J Rare Dis. 2015;10(1):58), doi:10.1186/s13023-015-0266-1
- Laemmle A, Gallagher RC, Keogh A, et al. Frequency and pathophysiology of acute liver failure in ornithine transcarbamylase deficiency (OTCD). PLoS One. 2016;11(4):e0153358.